Friday, 30 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Debt & Borrowing

Evoq Remedies Debt & Borrowing

Evoq Remedies Limited (BSE: 543500) has submitted its initial disclosure confirming it does not meet the SEBI criteria for 'Large Corporate' classification for the financial year. The company reported nil outstanding borrowings as of March 31, 2026. This regulatory filing ensures compliance with debt sourcing framework requirements.

Source

BSE filing, BSE: 543500. Summary written from the filing by ALFA Finder's alert engine.

Read the filing ↗

Evoq Remedies Ltd: key numbers

Share price
₹1.63
Market cap
₹4.06 Cr
Revenue (annual)
₹25.51 Cr
Net profit (annual)
₹-0.24 Cr
P/E (TTM)
-16.9×Sector 52.3×
Promoter holding
0.02%
FII holding
0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Evoq Remedies Ltd

All →

Other debt & borrowing announcements

All →